Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Assets Average (2020 - 2026)

Biodesix filings provide 7 years of Assets Average readings, the most recent being $91.1 million for Q1 2026.

  • On a quarterly basis, Assets Average fell 0.75% to $91.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $91.1 million, a 0.75% decrease, with the full-year FY2025 number at $92.4 million, down 5.92% from a year prior.
  • Assets Average hit $91.1 million in Q1 2026 for Biodesix, up from $88.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $109.3 million in Q3 2024 to a low of $68.4 million in Q2 2022.
  • Median Assets Average over the past 5 years was $88.1 million (2025), compared with a mean of $86.8 million.
  • Biggest five-year swings in Assets Average: plummeted 41.77% in 2022 and later skyrocketed 32.95% in 2024.
  • Biodesix's Assets Average stood at $78.1 million in 2022, then increased by 19.08% to $92.9 million in 2023, then rose by 7.59% to $100.0 million in 2024, then fell by 11.9% to $88.1 million in 2025, then increased by 3.36% to $91.1 million in 2026.
  • The last three reported values for Assets Average were $91.1 million (Q1 2026), $88.1 million (Q4 2025), and $88.2 million (Q3 2025) per Business Quant data.